Valuation (71%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 11.23 | 16.25 |
| PEG Ratio (TTM) | 6.55 | 1.70 |
| P/S Ratio (TTM) | 2.23 | 2.61 |
| P/B Ratio (TTM) | 1.41 | 1.90 |
| P/FCF Ratio (TTM) | 13.33 | 11.14 |
| Price to 5YR AVG Earnings Ratio | 13.78 | 14.10 |
| Price to 5YR AVG FCF Ratio | 10.58 | 8.07 |
Profitability (35%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 1.10% | 1,502.82% |
| ROE (TTM) | 13.31% | 8.88% |
| Net Profit Margin (TTM) | 19.82% | 15.60% |
| ROIC 5YR AVG | -34.89% | 20.57% |
Growth (60%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 2.95% | 30.40% | 12.80% |
| Revenue | 4.27% | 13.33% | 12.01% |
| Net Income | 2.70% | 25.49% | 8.20% |
| Cash Flow | 13.39% | -1,344.33% | -817.50% |
Health (51%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 0.31 | 3.19 |
| Quick Ratio (TTM) | 0.38 | 4.91 |
| D/E Ratio (TTM) | 0.09 | 1.27 |
| Interest Coverage (TTM) | 1.08 | 0.64 |
| Piotroski F-Score | 7 | 6 |
| Altman Z-Score | N/A | 0.38 |
| LTL to 5YR AVG FCF | 0.68 | 6.26 |
| Shares Outstanding Growth 5YR AVG | -4.01% | 4.88% |